McBriar J, Papadimitriou K, Golub D, Donaldson H, Li J, Khattar P
J Neurosurg Case Lessons. 2024; 8(4).
PMID: 39038366
PMC: 11284653.
DOI: 10.3171/CASE24238.
Busatto S, Yang Y, Walker S, Davidovich I, Lin W, Lewis-Tuffin L
J Nanobiotechnology. 2020; 18(1):162.
PMID: 33160390
PMC: 7648399.
DOI: 10.1186/s12951-020-00722-2.
Yang S, Kim H, Lee S, Jin S
Brain Tumor Res Treat. 2020; 8(2):103-108.
PMID: 33118342
PMC: 7595855.
DOI: 10.14791/btrt.2020.8.e15.
Cominetti M, Altei W, Selistre-de-Araujo H
Breast Cancer (Dove Med Press). 2019; 11:165-178.
PMID: 31114313
PMC: 6497883.
DOI: 10.2147/BCTT.S166725.
Ferrel E, Roehrig A, Kaya E, Carlson J, Ling B, Wagner A
Int J Mol Sci. 2016; 17(3):400.
PMID: 26999120
PMC: 4813255.
DOI: 10.3390/ijms17030400.
Ubiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinoma.
Hwang S, Lee H, Kim H, Lee H, Shin C, Yun S
Sci Rep. 2016; 6:21596.
PMID: 26883469
PMC: 4756316.
DOI: 10.1038/srep21596.
Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model.
Nakayama A, Takagi S, Yusa T, Yaguchi M, Hayashi A, Tamura T
J Cancer. 2013; 4(7):557-65.
PMID: 23983820
PMC: 3753530.
DOI: 10.7150/jca.6689.
Clinical implication of Time To Brain Metastasis (TTBM) according to breast cancer subtypes.
Ahn H, Park Y, Lee S, Park S, Maeng C, Park W
Springerplus. 2013; 2(1):136.
PMID: 23667803
PMC: 3647103.
DOI: 10.1186/2193-1801-2-136.
In vivo animal models for studying brain metastasis: value and limitations.
Daphu I, Sundstrom T, Horn S, Huszthy P, Niclou S, Sakariassen P
Clin Exp Metastasis. 2013; 30(5):695-710.
PMID: 23322381
DOI: 10.1007/s10585-013-9566-9.
EGFR mutation status in brain metastases of non-small cell lung carcinoma.
Burel-Vandenbos F, Ambrosetti D, Coutts M, Pedeutour F
J Neurooncol. 2012; 111(1):1-10.
PMID: 23086434
DOI: 10.1007/s11060-012-0990-5.
Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.
Wu Y, Muldoon L, Gahramanov S, Kraemer D, Marshall D, Neuwelt E
J Neurooncol. 2012; 110(1):27-36.
PMID: 22842979
PMC: 3726254.
DOI: 10.1007/s11060-012-0942-0.
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
Ahn H, Lee S, Park Y, Sohn J, Jo J, Ahn J
Neuro Oncol. 2012; 14(8):1105-13.
PMID: 22693244
PMC: 3408262.
DOI: 10.1093/neuonc/nos137.
Extracranial metastatic patterns on occurrence of brain metastases.
Vuong D, Rades D, Vo S, Busse R
J Neurooncol. 2011; 105(1):83-90.
PMID: 21394486
DOI: 10.1007/s11060-011-0563-z.
Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells.
Lorger M, Lee H, Forsyth J, Felding-Habermann B
J Neurooncol. 2011; 104(3):689-96.
PMID: 21359851
PMC: 4836850.
DOI: 10.1007/s11060-011-0550-4.
Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.
Lorger M, Felding-Habermann B
Am J Pathol. 2010; 176(6):2958-71.
PMID: 20382702
PMC: 2877856.
DOI: 10.2353/ajpath.2010.090838.
The vascular basement membrane as "soil" in brain metastasis.
Carbonell W, Ansorge O, Sibson N, Muschel R
PLoS One. 2009; 4(6):e5857.
PMID: 19516901
PMC: 2689678.
DOI: 10.1371/journal.pone.0005857.
Antiangiogenic therapy in brain tumors.
Lakka S, Rao J
Expert Rev Neurother. 2008; 8(10):1457-73.
PMID: 18928341
PMC: 2656359.
DOI: 10.1586/14737175.8.10.1457.
Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization.
Fitzgerald D, Palmieri D, Hua E, Hargrave E, Herring J, Qian Y
Clin Exp Metastasis. 2008; 25(7):799-810.
PMID: 18649117
PMC: 2679391.
DOI: 10.1007/s10585-008-9193-z.